Degassing system for intravascular lithotripsy system

The IVL system addresses inefficiencies by employing separate reservoirs and automated degassing, ensuring consistent shockwave intensity and reducing operator fatigue, thereby enhancing treatment efficacy.

WO2026136837A1PCT designated stage Publication Date: 2026-06-25CARDIOVASCULAR SYSTEMS INC

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
CARDIOVASCULAR SYSTEMS INC
Filing Date
2025-12-19
Publication Date
2026-06-25

AI Technical Summary

Technical Problem

Intravascular Lithotripsy (IVL) systems face inefficiencies due to gas bubbles attenuating shockwaves, electrode erosion, operator fatigue, and manual fluid evacuation challenges, leading to reduced treatment efficacy and potential damage.

Method used

A system using separate reservoirs for inflation and evacuation fluids, with a three-way valve and automated control, enables rapid and efficient degassing by alternating between positive and negative pressures, reducing manual intervention and improving treatment efficacy.

Benefits of technology

The system enhances IVL treatment efficacy by minimizing gas bubble interference, reducing operator fatigue, and maintaining consistent shockwave intensity, thus improving treatment outcomes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2025060597_25062026_PF_FP_ABST
    Figure US2025060597_25062026_PF_FP_ABST
Patent Text Reader

Abstract

Degassing or flushing an IVL catheter balloon. The method includes providing inflation fluid to a catheter balloon from a first fluid reservoir having a positive pressure to inflate the catheter balloon. The method further includes removing at least a portion of the inflation fluid from the catheter balloon to a second fluid reservoir, different from the first fluid reservoir having a negative pressure.
Need to check novelty before this filing date? Find Prior Art